AJANTA PHARMA
Back to Balance Sheet
|
AJANTA PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹6,247 Cr | ₹5,117 Cr | ₹4,504 Cr | ₹4,705 Cr | ₹4,197 Cr |
What is the latest Total Liabilities ratio of AJANTA PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹6,247 Cr |
| Mar2025 | ₹5,117 Cr |
| Mar2024 | ₹4,504 Cr |
| Mar2023 | ₹4,705 Cr |
| Mar2022 | ₹4,197 Cr |
How is Total Liabilities of AJANTA PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹6,247 Cr | 22.07 | |
| Mar2025 | ₹5,117 Cr | 13.62 | |
| Mar2024 | ₹4,504 Cr | -4.27 | |
| Mar2023 | ₹4,705 Cr | 12.10 | |
| Mar2022 | ₹4,197 Cr | - | |
Compare Total Liabilities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹41,471.9 Cr | 1.4% | -6.2% | 46.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 1.4% |
-6.2% |
46.9% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses